Skip to main content
Top
Published in: Tumor Biology 7/2016

01-07-2016 | Original Article

Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population

Authors: Guangli Yin, Zhengrui Xiao, Ying Ni, Xiaoyan Qu, Hanxin Wu, Hua Lu, Sixuan Qian, Lijuan Chen, Jianyong Li, Hairong Qiu, Kourong Miao

Published in: Tumor Biology | Issue 7/2016

Login to get access

Abstract

Multidrug resistance 1 (MDR1) gene encodes P-glycoprotein (P-gp), which acts as an efflux pump and provides cell protection against various substances, and its single-nucleotide polymorphisms (SNPs) are associated with the development of malignant hematologic diseases. The present study aimed at investigating whether the MDR1 SNPs and haplotype variants were correlated with the susceptibility to multiple myeloma (MM). A total of 115 MM patients and 153 healthy controls from Jiangsu Han population were enrolled and genotyped by polymerase chain reaction–allele-specific primer (PCR-ASP) method or DNA direct sequencing at MDR1 loci of C1236T, G2677T/A, and C3435T. No significance was found in the distribution of alleles and genotypes in MDR1 three loci. Diplotype analysis has also demonstrated no effect in susceptibility to MM. But, in haplotype analysis, the haplotype of T–G–T was significantly more common than healthy controls (12.6 % in MM group vs. 1.7 % in control group, odds ratios (ORs) = 8.7, 95 % confidence interval (CI) 3.3–22.8, Pc< 0.01). Our results pointed out that comparable allele, genotype, and diplotype frequencies among MM patients and controls in Chinese Jiangsu Han population were found; the frequency of T–G–T haplotype was significantly increased in MM group compared with the control group, which indicated that this haplotype might be associated with the susceptibility to MM.
Literature
1.
go back to reference Sauna ZE, Kim IW, Ambudkar SV. Genomics and the mechanism of P-glycoprotein (ABCB1). J Bioenerg Biomembr. 2007;39:481–7.CrossRefPubMed Sauna ZE, Kim IW, Ambudkar SV. Genomics and the mechanism of P-glycoprotein (ABCB1). J Bioenerg Biomembr. 2007;39:481–7.CrossRefPubMed
3.
go back to reference Vine J, Cohen SB, Ruchlemer R, Goldschmidt N, Levin M, Libster D, et al. Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia. Leuk Lymphoma. 2014;55:2525–31.CrossRefPubMed Vine J, Cohen SB, Ruchlemer R, Goldschmidt N, Levin M, Libster D, et al. Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia. Leuk Lymphoma. 2014;55:2525–31.CrossRefPubMed
4.
go back to reference Yue Q, Xiong B, Chen L, Chen Y, Bu F, Liu X, et al. MDR1 C3435T polymorphism and childhood acute lymphoblastic leukemia susceptibility: an updated meta-analysis. Biomed Pharmacother. 2015;69:76–81.CrossRefPubMed Yue Q, Xiong B, Chen L, Chen Y, Bu F, Liu X, et al. MDR1 C3435T polymorphism and childhood acute lymphoblastic leukemia susceptibility: an updated meta-analysis. Biomed Pharmacother. 2015;69:76–81.CrossRefPubMed
5.
go back to reference Ma L, Liu H, Ruan L, Yang X, Yang H, Feng Y. Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: a meta-analysis. Biomed Rep. 2015;3:83–7.PubMed Ma L, Liu H, Ruan L, Yang X, Yang H, Feng Y. Multidrug resistance gene 1 C1236T polymorphism and susceptibility to leukemia: a meta-analysis. Biomed Rep. 2015;3:83–7.PubMed
6.
go back to reference Kim HN, Kim NY, Yu L, Kim YK, Lee IK, Yang DH, et al. Polymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma. Int J Mol Sci. 2014;15:6703–16.CrossRefPubMedPubMedCentral Kim HN, Kim NY, Yu L, Kim YK, Lee IK, Yang DH, et al. Polymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma. Int J Mol Sci. 2014;15:6703–16.CrossRefPubMedPubMedCentral
7.
go back to reference Ni Y, Xiao Z, Yin G, Fan L, Wang L, Zhu H, et al. The single nucleotide polymorphism and haplotype analysis of MDR1 in Chinese diffuse large B cell lymphoma patients. Biomed Pharmacother. 2015;73:24–8.CrossRefPubMed Ni Y, Xiao Z, Yin G, Fan L, Wang L, Zhu H, et al. The single nucleotide polymorphism and haplotype analysis of MDR1 in Chinese diffuse large B cell lymphoma patients. Biomed Pharmacother. 2015;73:24–8.CrossRefPubMed
8.
go back to reference Dong HJ, Miao KR, Qiao C, Zhuang Y, Shen WY, Hong M, et al. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population. Leuk Lymphoma. 2011;52:1003–9.CrossRefPubMed Dong HJ, Miao KR, Qiao C, Zhuang Y, Shen WY, Hong M, et al. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population. Leuk Lymphoma. 2011;52:1003–9.CrossRefPubMed
9.
go back to reference Amend SR, Wilson WC, Chu L, Lu L, Liu P, Serie D, et al. Whole genome sequence of multiple myeloma-prone C57BL/KaLwRij mouse strain suggests the origin of disease involves multiple cell types. PLoS One. 2015;10(5):e0127828.CrossRefPubMedPubMedCentral Amend SR, Wilson WC, Chu L, Lu L, Liu P, Serie D, et al. Whole genome sequence of multiple myeloma-prone C57BL/KaLwRij mouse strain suggests the origin of disease involves multiple cell types. PLoS One. 2015;10(5):e0127828.CrossRefPubMedPubMedCentral
10.
go back to reference Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: WHO; 2008. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: WHO; 2008.
11.
go back to reference Qiu H, Dong H, Pan S, Miao K. The single nucleotide polymorphism and haplotype analysis of MDR1 in Jiangsu Han population of China. Biomed Pharmacother. 2012;66:459–63.CrossRefPubMed Qiu H, Dong H, Pan S, Miao K. The single nucleotide polymorphism and haplotype analysis of MDR1 in Jiangsu Han population of China. Biomed Pharmacother. 2012;66:459–63.CrossRefPubMed
12.
go back to reference Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinformatics Online. 2005;1:47–50. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinformatics Online. 2005;1:47–50.
13.
14.
go back to reference Gutierrez-Rubio SA, Quintero-Ramos A, Duran-Cardenas A, Franco-Topete RA, Castro-Cervantes JM, Oceguera-Villanueva A, et al. 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients. Genet Mol Res. 2015;14:1250–9.CrossRefPubMed Gutierrez-Rubio SA, Quintero-Ramos A, Duran-Cardenas A, Franco-Topete RA, Castro-Cervantes JM, Oceguera-Villanueva A, et al. 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients. Genet Mol Res. 2015;14:1250–9.CrossRefPubMed
15.
go back to reference Pongstaporn W, Pakakasama S, Chaksangchaichote P, Pongtheerat T, Hongeng S, Permitr S. MDR1 C3435T and C1236T polymorphisms: association with high-risk childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2015;16:2839–43.CrossRefPubMed Pongstaporn W, Pakakasama S, Chaksangchaichote P, Pongtheerat T, Hongeng S, Permitr S. MDR1 C3435T and C1236T polymorphisms: association with high-risk childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2015;16:2839–43.CrossRefPubMed
16.
go back to reference Yaya K, Hind D, Meryem Q, Asma Q, Said B, Sellama N. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia. Tumour Biol. 2014;35:10969–75.CrossRefPubMed Yaya K, Hind D, Meryem Q, Asma Q, Said B, Sellama N. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia. Tumour Biol. 2014;35:10969–75.CrossRefPubMed
17.
go back to reference Mhaidat NM, Alshogran OY, Khabour OF, Alzoubi KH. MatalkaII, Haddadin WJ, et al. Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin’s lymphoma. J Exp Clin Cancer Res. 2011;30:68.CrossRefPubMedPubMedCentral Mhaidat NM, Alshogran OY, Khabour OF, Alzoubi KH. MatalkaII, Haddadin WJ, et al. Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin’s lymphoma. J Exp Clin Cancer Res. 2011;30:68.CrossRefPubMedPubMedCentral
18.
go back to reference Drain S, Catherwood MA, Orr N, Galligan L, Rea IM, Hodkinson C, et al. ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma. Leuk Lymphoma. 2009;50:566–70.CrossRefPubMed Drain S, Catherwood MA, Orr N, Galligan L, Rea IM, Hodkinson C, et al. ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma. Leuk Lymphoma. 2009;50:566–70.CrossRefPubMed
19.
go back to reference Ni Y, Yin G, Xiao Z, Fan L, Wang L, Wu Y, et al. MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients. Tumour Biol. 2015 Aug 19. Ni Y, Yin G, Xiao Z, Fan L, Wang L, Wu Y, et al. MDR1 polymorphisms have an impact on the prognosis of Chinese diffuse large B cell lymphoma patients. Tumour Biol. 2015 Aug 19.
20.
go back to reference Ni LN, Li JY, Miao KR, Qiao C, Zhang SJ, Qiu HR, et al. Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia. Med Oncol. 2011;28(1):265–9.CrossRefPubMed Ni LN, Li JY, Miao KR, Qiao C, Zhang SJ, Qiu HR, et al. Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia. Med Oncol. 2011;28(1):265–9.CrossRefPubMed
21.
go back to reference Buda G, Ricci D, Huang CC, Favis R, Cohen N, Zhuang SH, et al. Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin. Ann Hematol. 2010;89(11):1133–40.CrossRefPubMedPubMedCentral Buda G, Ricci D, Huang CC, Favis R, Cohen N, Zhuang SH, et al. Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin. Ann Hematol. 2010;89(11):1133–40.CrossRefPubMedPubMedCentral
22.
go back to reference Maggini V, Buda G, Martino A, Presciuttini S, Galimberti S, Orciuolo E, et al. MDR1 diplotypes as prognostic markers in multiple myeloma. Pharmacogenet Genomics. 2008;18(5):383–9.CrossRefPubMed Maggini V, Buda G, Martino A, Presciuttini S, Galimberti S, Orciuolo E, et al. MDR1 diplotypes as prognostic markers in multiple myeloma. Pharmacogenet Genomics. 2008;18(5):383–9.CrossRefPubMed
23.
go back to reference Jamroziak K, Balcerczak E, Calka K, Piaskowski S, Urbanska-Rys H, Salagacka A, et al. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma. Leuk Res. 2009;33(2):332–5.CrossRefPubMed Jamroziak K, Balcerczak E, Calka K, Piaskowski S, Urbanska-Rys H, Salagacka A, et al. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma. Leuk Res. 2009;33(2):332–5.CrossRefPubMed
24.
go back to reference Lardo M, Castro M, Moiraghi B, Rojas F, Borda N, Rey JA, et al. MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia. Blood Res. 2015;50(3):154–9.CrossRefPubMedPubMedCentral Lardo M, Castro M, Moiraghi B, Rojas F, Borda N, Rey JA, et al. MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia. Blood Res. 2015;50(3):154–9.CrossRefPubMedPubMedCentral
25.
go back to reference Sheng X, Zhang L, Tong N, Luo D, Wang M, Xu M, et al. MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case–control studies. Mol Biol Rep. 2012;39:7237–49.CrossRefPubMed Sheng X, Zhang L, Tong N, Luo D, Wang M, Xu M, et al. MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case–control studies. Mol Biol Rep. 2012;39:7237–49.CrossRefPubMed
26.
go back to reference Bellusci CP, Rocco C, Aulicino P, Mecikovsky D, Curras V, Hegoburu S, et al. Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children. Gene. 2013;522(1):96–101.CrossRefPubMed Bellusci CP, Rocco C, Aulicino P, Mecikovsky D, Curras V, Hegoburu S, et al. Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children. Gene. 2013;522(1):96–101.CrossRefPubMed
27.
28.
go back to reference Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T, et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther. 2002;71:297–303.CrossRefPubMed Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T, et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther. 2002;71:297–303.CrossRefPubMed
29.
go back to reference Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS, et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics. 2002;12:437–50.CrossRefPubMed Tang K, Ngoi SM, Gwee PC, Chua JM, Lee EJ, Chong SS, et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics. 2002;12:437–50.CrossRefPubMed
30.
go back to reference Shen LX, Basilion JP, Stanton Jr VP. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A. 1999;96:7871–6.CrossRefPubMedPubMedCentral Shen LX, Basilion JP, Stanton Jr VP. Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A. 1999;96:7871–6.CrossRefPubMedPubMedCentral
31.
go back to reference Perloff MD, von Moltke LL, Störmer E, Shader RI, Greenblatt DJ. Saint John’s wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol. 2001;134:1601–8.CrossRefPubMedPubMedCentral Perloff MD, von Moltke LL, Störmer E, Shader RI, Greenblatt DJ. Saint John’s wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol. 2001;134:1601–8.CrossRefPubMedPubMedCentral
Metadata
Title
Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population
Authors
Guangli Yin
Zhengrui Xiao
Ying Ni
Xiaoyan Qu
Hanxin Wu
Hua Lu
Sixuan Qian
Lijuan Chen
Jianyong Li
Hairong Qiu
Kourong Miao
Publication date
01-07-2016
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 7/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-015-4574-9

Other articles of this Issue 7/2016

Tumor Biology 7/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine